U.S Diagnostics

What U.S Diagnostics does

U.S. Diagnostics, Inc. is a privately held U.S. medical device company founded in March 2005 and headquartered at 711 3rd Avenue, New York, NY. The company develops, manufactures, and distributes a portfolio of capillary whole-blood glucose monitoring systems — Infinity, EasyGluco, EasyGluco Plus, Control, and VeraSens — that use biosensor technology with plasma-equivalent calibration, FDA-cleared for both home and clinical use. Each system requires its own proprietary test strips and control solutions, generating recurring consumables revenue from a $17.95/50-strip box list price, while meters are sold at low entry-price kits ($9.95–$15.95) to accelerate adoption and lock in strip demand.

The business operates a multi-channel go-to-market: a direct-to-consumer e-commerce storefront (shop.usdiagnostics.net), toll-free phone ordering, retail pharmacy distribution (with insurance plan coverage in the U.S.), and exclusive international distribution partners — Sentech Corp for Western Africa (Senegal, Mali, Mauritania, Guinea, Equatorial Guinea; with active expansion into Côte d'Ivoire, Niger, Ghana) and Servicios Diabeticos de Puerto Rico for the Caribbean. Warehousing in New Jersey and Florida supports nationwide U.S. fulfillment. The company reports having served over 1 million diabetic patients since inception and offers bundled consumable pricing (4- and 5-box strip bundles with free starter kits or diabetic socks) and a lifetime free replacement warranty on Infinity meters.

The product portfolio also extends to diabetes accessories — lancets, safety lancets, lancing devices, insulin pen needles, insulin syringes, software cables, diabetic socks, and CR2032 lithium batteries — and the company maintains registered trademarks on each meter line. Multiple product lines (EasyGluco Plus, Control, VeraSens) are currently flagged as discontinued on the storefront. The company has no parent, no external investors, no disclosed funding rounds, and headcount of 1–10, indicating a lean, founder-operated commercial entity with a value-tier positioning in a market increasingly dominated by connected continuous-glucose-monitor platforms.

Name

U.S Diagnostics

Legal name

US Diagnostics, Inc.

Website

https://usdiagnostics.net

Company type

Private

Founded year

2005

Operating status

Operating

Headcount range

11–50 employees

Short description

U.S. Diagnostics is a New York-based, privately held medical device company that manufactures and sells FDA-cleared capillary blood glucose meters (Infinity, EasyGluco, VeraSens, Control) and proprietary test strips to individual diabetic patients across the U.S., Puerto Rico, and West Africa.

Ownership category

akta.pro rank

Product category

Blood Glucose Monitoring Systems

NAICS

Electromedical and Electrotherapeutic Apparatus Manufacturing (334510)

SIC

Electromedical & Electrotherapeutic Apparatus (3845)

akta.pro industry

PRIMARYHLAHAHAG

Blood Glucose Monitoring (BGM) Meters & Test Strips

Healthcare & Life Sciences/Medical Devices & Diagnostics/Diabetes Care Devices (CGM, Insulin Delivery)

SECONDARYHLAHAOAB

Blood Glucose & Metabolic POCT (Glucose, Ketones, Lactate)

Healthcare & Life Sciences/Medical Devices & Diagnostics/Point-of-Care Testing (POCT) & Rapid Diagnostics

SECONDARYHLAHAHAE

Insulin Pen Needles, Syringes & Infusion Sets (Consumables)

Healthcare & Life Sciences/Medical Devices & Diagnostics/Diabetes Care Devices (CGM, Insulin Delivery)

SECONDARYCRACAQAE

Blood Glucose Monitoring Devices (Consumer CGM & Smart Glucometers)

Consumer Products & Retail/Consumer Electronics & Appliances Retail/Personal Health & Wellness Devices (Smart Scales, BP/ECG Monitors, Sleep Devices)

Keywords

• Blood glucose monitors
• Diabetes testing supplies
• Glucose test strips
• Lancing devices lancets
• Insulin pen needles

Headquarters

HQ city

New York

HQ country

United States

HQ region

North America

Offices4 records

Markets served

GTM type

B2C

Offering type

Hardware or Manufacturing

Cost components

Supply Chain, Operations, Personnel, Marketing or Sales, Technology or R&D, Infrastructure

Revenue model

1. Blood Glucose Monitoring Systems (Meters): One-time sale of blood glucose meters (Infinity®, EasyGluco®, EasyGluco Plus®, Control®, VeraSens®). Meters sold at low entry prices including Meter Kit ($9.95) and Starter Kit ($15.95) to drive consumables adoption.
2. Test Strips and Consumables: Recurring revenue from proprietary test strips (box of 50, ~$17.95 per box), control solutions, lancets, lancing devices, and batteries. Each meter system requires its own dedicated test strips.
3. Diabetes Accessories: Sales of complementary products including lancing devices ($3.95), lancets ($2.95), safety lancets ($12.95), insulin syringes, insulin pen needles, diabetic socks ($14.95), software cables ($14.95), and batteries ($3.00).

Pricing tiers

Go-to-market motion3 records

Distribution channels5 records

Marketing channels5 records

Core offering

U.S. Diagnostics manufactures and supplies branded blood glucose monitoring systems (Infinity®, EasyGluco®, EasyGluco Plus®, VeraSens®, and Control®) along with proprietary test strips, control solutions, and accessory supplies (lancets, lancing devices, insulin pen needles, insulin syringes, software cables, diabetic socks, batteries) for diabetic self-monitoring at home and in clinical settings. The company operates its own e-commerce storefront and distributes through retail pharmacies in the United States and via exclusive international distributors in Puerto Rico and Western Africa.

Product overview

U.S Diagnostics is a medical device company that develops, manufactures, and distributes blood glucose monitoring systems and diabetes management supplies. The product portfolio consists of five core blood glucose monitoring systems: Infinity® (flagship product with automatic coding, 5-second results, 365 memory), EasyGluco® (basic model, 9-second results, 200 memory), EasyGluco Plus® (discontinued, with LED backlight and strip ejector), Control® (discontinued, with PC download capability), and VeraSens® (discontinued, with no-coding feature and hypoglycemia indicator). Supporting the meters are proprietary test strips and control solutions for each system, along with accessory products including lancets, safety lancets, lancing devices, insulin pen needles, insulin syringes, software cables for PC data transfer, diabetic socks, and lithium batteries. The company also offers bundle promotions for consumable purchases. All systems use capillary whole blood measurement technology with plasma-equivalent calibration and are FDA approved for home and clinical use.

Differentiator

Problem solved

Functional benefit

Brands

• Infinity®: Blood Glucose Monitoring System with biosensor technology, 5-second results, 365 test memory, 7-90 day averaging, automatic coding.
• EasyGluco®
• EasyGluco Plus®
• VeraSens®
• Control®

Products and services

• Infinity® Blood Glucose Monitoring System Advanced blood glucose monitoring system using biosensor technology providing accurate and reliable results in 5 seconds. Features automatic coding, 365 test memory, 7–90 day averaging, 1000 test battery life, strip ejector, and alternate site testing capability for palm, forearm, upper arm, calf, thigh, and fingertips. FDA approved for home and clinical use.
• EasyGluco® Blood Glucose Monitoring System Blood glucose monitoring system with bio-sensor technology providing fast, accurate, and reliable results in 9 seconds. Features capillary action blood draw, small sample size, 200 test memory, and alternate site testing (forearm, thigh, calf, palm, and fingertips).
• EasyGluco Plus® Blood Glucose Monitoring System Blood glucose monitoring system with automatic coding that delivers fast and accurate results in 5 seconds. Features LED backlight, strip ejector, 365+ test memory, 7–90 day averaging, and alternate site testing capability. Listed on the catalog as discontinued for new purchases.
• VeraSens® Blood Glucose Monitoring System Blood glucose monitoring system with no-coding feature for ease of use. Features large LCD display, 5-second test time, 1000 test memory, 3000 test battery life, hypoglycemia indicator, strip expiration indicator, and pre-meal/post-meal/fasting result flagging. Listed on the catalog as discontinued for new purchases.
• Control® Blood Glucose Monitoring System Blood glucose monitoring system providing accurate and reliable results in 5 seconds with only a small blood sample. Features 250+ test memory, 14-day averaging, PC download capability via proprietary software, alternate site testing, biosensor technology, and 5000 test battery life. Listed on the catalog as discontinued for new purchases.
• Infinity® Test Strips (Box of 50) Test strips for use with Infinity® Blood Glucose Meters. Small sample size (0.5 µL) with automatic blood draw and visual confirmation of sufficient blood sample. Sold at ~$17.95 per box of 50, with bundle discounts on multi-box purchases.
• EasyGluco® Test Strips (Box of 50) Test strips for use with EasyGluco® Blood Glucose Meters with automatic capillary blood draw and visual indication of adequate sample. Sold at ~$17.95 per box of 50 with bundle pricing available.
• EasyGluco Plus® Test Strips (Box of 50) Test strips for use with EasyGluco Plus® Blood Glucose Meters with automatic blood draw. Listed on the catalog as discontinued.
• Control® Test Strips (Box of 50) Test strips for use with Control® Blood Glucose Meters with automatic blood draw and visual confirmation for accurate readings.
• Infinity® Control Solutions Control solution for verifying accuracy of Infinity® meter and test strips. Should be used weekly and when opening new test strip vials. Sold at $3.95.
• EasyGluco® Control Solutions Control solution for verifying accuracy of EasyGluco® meter and test strips. Weekly testing recommended along with new vial openings.
• US Diagnostics Lancets (Box of 100) Sterile, disposable lancets available in 30 gauge compatible with most standard lancing devices. Features smooth tri-bevel point for comfortable sampling and thin tip for less painful penetration. Sold at $2.95 per box of 100.
• US Diagnostics Safety Lancets Sterile, single-use, disposable safety lancets with tri-bevel tip for painless sampling. Ready to use with no loading needed, pressure activated, and does not require a lancing device. Latex free. Sold at $12.95.
• US Diagnostics Lancing Device Small, spring-loaded pen device for obtaining capillary blood samples with adjustable tip offering five settings for maximum comfort. Compatible with most standard lancets. Sold at $3.95.
• US Diagnostics Insulin Pen Needles Insulin pen needles intended for use with pen injector devices for subcutaneous injection of fluids including insulin and exenatide. Available in multiple gauges (32G, 31G, 30G) and lengths (4mm to 8mm) with universal fit compatibility. Features electro-polished, triple-sharpened beveled-edge needles made of surgical grade stainless steel.
• US Diagnostics Insulin Syringes High quality insulin syringes with surgical grade stainless steel, electro-polished ultra-sharp needles with tri-bevel cut tip and coating for soft injection. Permanently attached needle with easy-to-read scale markings. Available in 30G and 31G gauges, in 1cc, 1/2cc, and 3/10cc sizes, all with 5/16 inch length. Does not contain natural rubber latex.
• Software Cable USB cable for connecting Infinity® and EasyGluco® Blood Glucose Monitors to PC for data transfer. Enables viewing and printing of test result graphs and charts using proprietary meter software. Sold at $14.95.
• Diabetic Socks Maximum stretch around calf for enhanced circulation, minimum toe sewing line to reduce pressure and blistering, superior quality cotton with double layer bottom cushion for comfortable wear and excellent sweat absorption. Pack of 3 pairs, Medium size for Men 8-10 and Women 9-10. Sold at $14.95.
• Lithium Battery (CR2032) 3V Lithium CR2032 battery for use with blood glucose monitoring systems. Sold at $3.00.
• Infinity® Meter Kit Complete kit including Infinity® meter, control solution, carrying case, log book, quick reference guide, and 2 CR2032 batteries. Sold at $9.95 as a low entry-price bundle.
• Infinity® Starter Kit Starter package including Infinity® Blood Glucose Meter, control solution, 25 test strips, lancing device, and 10 lancets. Sold at $15.95 as an entry bundle that seeds initial consumable use.

Quantifiable outcome

• Correlation coefficient R=0.9832 between Infinity® and Hitachi 747 laboratory instrument
• +3 more outcomes

Named customers3 records

Segments3 records

Ideal customer profiles3 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature5 records

Partnerships

Two partnerships are on record, tiered core.

• Sentech CorpcoreChannel Partner/ Reseller/ Distributor · 1 January 2018Sentech Corp, located in Dakar, Senegal, is the exclusive distributor of INFINITY® Blood Glucose Monitoring System in Western Africa. The partnership began with distribution to Senegal and expanded to Mali, Mauritania, Guinea, and Equatorial Guinea. Sentech Corp has been working in the diabetes industry since 2009, distributing affordable diabetic testing supplies to hospitals, clinics, and pharmacies. They are a member of the Diabetic Association of Senegal and have contracts with the Department of Health and military hospitals of Senegal. Currently working on distribution contracts for Côte d'Ivoire, Niger, and Ghana. CEO Ousmane Faye states the partnership helps diabetics in Africa receive the supplies they desperately need.
• Servicios Diabeticos de Puerto RicocoreChannel Partner/ Reseller/ Distributor · 1 January 2007For over a decade, US Diagnostics and Servicios Diabeticos de Puerto Rico have partnered to provide affordable, top-quality diabetic supplies to customers in Puerto Rico. Servicios Diabeticos, located in San Juan since 2002, is focused on bringing innovative and affordable technology to diabetics across the island. They service numerous pharmacies and INFINITY® is one of the top brands recommended by their clients due to ease of use and accurate results. COO Kris Rivera explains their objective is to educate patients and deliver affordable quality products that assist in daily diabetes management.

Scale indicators6 records

Recent moves7 records

Expansion highlights6 records

Direct peers

• LifeScan (OneTouch): LifeScan manufactures and sells OneTouch branded blood glucose meters, test strips, and lancing devices through consumer and pharmacy channels globally—directly comparable on product category, customer base (diabetic self-monitors), and razor/blade consumable model used by U.S. Diagnostics.
• Ascensia Diabetes Care: Ascensia markets the Contour Next portfolio of BGM meters and proprietary strips, sold through retail pharmacy and DTC. Closely matches U.S. Diagnostics' channel mix, price-tier strategy, and meter-to-strip consumable model.
• Roche Diabetes Care: Roche's Accu-Chek is one of the largest global BGM platforms with proprietary strips, hospital/clinical channels, and consumer pharmacy distribution—directly overlapping U.S. Diagnostics' product set, including FDA-cleared clinical-use claims.
• Trividia Health: Trividia markets TRUE METRIX and other affordable BGM systems in U.S. retail pharmacy and value channels, with proprietary strip lock-in—the most direct price-tier competitor to U.S. Diagnostics' Infinity® line.
• ARKRAY USA: ARKRAY produces the GLUCOCARD line of blood glucose meters and strips distributed through pharmacies and clinical channels—directly comparable to U.S. Diagnostics' meter portfolio, consumable model, and pharmacy retail strategy.
• AgaMatrix: AgaMatrix develops and supplies BGM meters and test strips (including private-label for retailers), with focus on affordable consumer and pharmacy channels—a niche direct peer comparable to U.S. Diagnostics on product and channel.
• i-SENS: i-SENS manufactures CareSens and other BGM systems with proprietary strips and serves global markets including emerging economies—comparable to U.S. Diagnostics on product line, consumable model, and international distribution through regional partners.

Broad incumbents

• Abbott Diabetes Care: Abbott sells FreeStyle blood glucose meters historically and now leads CGM (FreeStyle Libre) in retail pharmacy and DTC. Overlaps U.S. Diagnostics in BGM at retail but operates across a much broader diabetes portfolio including CGM.
• Medtronic Diabetes: Medtronic offers Guardian CGM, insulin pumps, and BGM products through clinical and patient channels—comparable on the consumable-strip category and on targeting the same diabetes patient base, but spanning a much larger portfolio including pump therapy.

Emerging players

• Dexcom: Dexcom is the dominant CGM platform (G6/G7) increasingly replacing fingerstick BGM as standard of care. Relevant as the disruptive category leader reshaping the BGM market in which U.S. Diagnostics operates.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat4 records

Key risks7 records

Key highlights7 records

Customer concentration

• Facebookfacebook.com/USDiagnosticsINC
• LinkedInlinkedin.com/company/u.s.-diagnostics

Revenue estimate

Valuation estimate

Number of profiles

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about U.S Diagnostics